These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2160518)

  • 1. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.
    Penney JB; Maragos WF; Greenamyre JT; Debowey DL; Hollingsworth Z; Young AB
    J Neurol Neurosurg Psychiatry; 1990 Apr; 53(4):314-20. PubMed ID: 2160518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
    Jansen KL; Faull RL; Dragunow M; Synek BL
    Neuroscience; 1990; 39(3):613-27. PubMed ID: 1965859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
    Greenamyre JT; Penney JB; D'Amato CJ; Young AB
    J Neurochem; 1987 Feb; 48(2):543-51. PubMed ID: 2878980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: non-N-methyl-D-aspartate receptors.
    Geddes JW; Ułas J; Brunner LC; Choe W; Cotman CW
    Neuroscience; 1992 Sep; 50(1):23-34. PubMed ID: 1328933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J; Brunner LC; Geddes JW; Choe W; Cotman CW
    Neuroscience; 1992 Jul; 49(1):45-61. PubMed ID: 1407551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor losses in putamen from patients with Huntington's disease.
    Young AB; Greenamyre JT; Hollingsworth Z; Albin R; D'Amato C; Shoulson I; Penney JB
    Science; 1988 Aug; 241(4868):981-3. PubMed ID: 2841762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus.
    Dewar D; Chalmers DT; Graham DI; McCulloch J
    Brain Res; 1991 Jul; 553(1):58-64. PubMed ID: 1933277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.
    Greenamyre JT; Olson JM; Penney JB; Young AB
    J Pharmacol Exp Ther; 1985 Apr; 233(1):254-63. PubMed ID: 2984415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex.
    Carlson MD; Penney JB; Young AB
    Neurobiol Aging; 1993; 14(4):343-52. PubMed ID: 7690114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
    Dure LS; Young AB; Penney JB
    Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy.
    McDonald JW; Garofalo EA; Hood T; Sackellares JC; Gilman S; McKeever PE; Troncoso JC; Johnston MV
    Ann Neurol; 1991 May; 29(5):529-41. PubMed ID: 1650160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.
    Geddes JW; Chang-Chui H; Cooper SM; Lott IT; Cotman CW
    Brain Res; 1986 Dec; 399(1):156-61. PubMed ID: 2879613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of hippocampal [3H]TCP binding in Alzheimer's disease.
    Maragos WF; Chu DC; Young AB; D'Amato CJ; Penney JB
    Neurosci Lett; 1987 Mar; 74(3):371-6. PubMed ID: 3031556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]TCP binding sites in Alzheimer's disease.
    Monaghan DT; Geddes JW; Yao D; Chung C; Cotman CW
    Neurosci Lett; 1987 Jan; 73(2):197-200. PubMed ID: 3029638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory and excitatory amino acid neurotransmitter binding sites in cynomolgus monkey (Macaca fascicularis) cervical spinal cord.
    Albin RL; Hollingsworth Z; Sakurai SY; Gilman S
    Brain Res; 1993 Feb; 604(1-2):354-7. PubMed ID: 8096159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course.
    Gao XM; Tamminga CA
    Synapse; 1996 Aug; 23(4):274-9. PubMed ID: 8855512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord.
    Jansen KL; Faull RL; Dragunow M; Waldvogel H
    Neurosci Lett; 1990 Jan; 108(1-2):53-7. PubMed ID: 1689476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.